Balance Sheet Details (Tables)

9 Months Ended

Sep. 30, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Current Assets and Prepaid Expenses

Other Current Assets and Prepaid Expenses consist of (in thousands):

	September 30, 2026		December 31, 2025
Prepaid clinical and related costs	$	1,201	$	2,064
VAT receivable	410		333
Research grant	—		3,789
Prepaid insurance	671		369
Other	842		831
Total	$	3,124	$	7,386

Schedule of Accounts Payable and Accrued Expenses

Accounts Payable consist of (in thousands):

	September 30, 2026		December 31, 2025
Clinical costs	$	9,396	$	9,493
Legal and audit costs	86		262
Other	638		383
Total	$	10,120	$	10,138

Accrued Expenses consist of (in thousands):

	September 30, 2026		December 31, 2025
Accrued clinical and related costs	$	15,471	$	16,102
Accrued legal and audit costs	155		137
Accrued compensation	1,703		2,168
Pre-commercial planning costs	1,199		—
Accrued other	1,530		238
Total	$	20,058	$	18,645

Schedule of Other Current Liabilities

Other Current Liabilities consist of (in thousands):

	September 30, 2026		December 31, 2025
Lease liabilities	$	246	$	470
SARs liability	—		809
Other	1,126		556
Total	$	1,372	$	1,835